Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Venetoclax in Combination with Hypomethylating Agents Compared to Standard Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia

Leila Mohassel, Hanna Yakubi, Kendra Jones, Hongkun Wang, Danielle Shafer

Blood (2022) 140 (Supplement 1): 6158–6159.

https://doi.org/10.1182/blood-2022-160260

Published: 2022

Journal Articles

Primary Ocular Lymphoma: A SEER Database Analysis of Patterns of Involvement and Outcomes

Arushi Khurana, MBBS, Taha Al-Juhaishi, MD, Victor Yazbeck, MD, Danielle Shafer, DO

Blood (2019) 134 (Supplement_1): 4013.

https://doi.org/10.1182/blood-2019-132011

Published: 2019

Journal Articles

Impact of Histologic Type on Survival in Primary Parotid Lymphomas

Taha Al-Juhaishi, MD, Arushi Khurana, MBBS, Danielle Shafer, DO, Victor Yazbeck, MD

Blood (2019) 134 (Supplement_1): 5882.

https://doi.org/10.1182/blood-2019-130981

Published: 2019

Journal Articles

Favorable Outcomes of Acute Leukemia of Ambiguous Lineage Treated with Hypercvad: A Multi-Center Retrospective Study

Vu H. Duong, MD, Kebede H. Begna, MD, Kendra L. Sweet, MD, Eunice S. Wang, MD, Ryan James Caddell, PharmD, Danielle Shafer, DO, Zeba Singh, MBBS, Maria R. Baer, MD, Aref Al-Kali, MD

Blood (2018) 132 (Supplement 1): 2658.

https://doi.org/10.1182/blood-2018-99-115448

Published: 2018

Journal Articles

Secondary Skin Involvement in Non-Hodgkin's Lymphoma Does Not Impact Outcomes: SEER Database Analysis

Arushi Khurana, MBBS, Taha Al-Juhaishi, MD, Danielle Shafer, DO

Blood (2018) 132 (Supplement 1): 2895.

https://doi.org/10.1182/blood-2018-99-120257

Published: 2018

Journal Articles

Disseminated histoplasmosis in peripheral blood smear

Haeseong Park, Danielle Shafer

Blood (2014) 123 (10): 1445.

https://doi.org/10.1182/blood-2013-11-540120

Published: 2014

Journal Articles

The Efficacy and Safety of the Addition of Rituximab to CHOP or a CHOP-Like Regimen In First Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Meta-Analysis

Aaron T Gerds, MD, Laura C Michaelis, MD, Danielle Shafer, DO

Blood (2010) 116 (21): 4913.

https://doi.org/10.1182/blood.V116.21.4913.4913

Published: 2010

Journal Articles

Azacitadine and Low-Dose Gemtuzumab Ozogamicin for the Treatment of Poor-Risk Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Relapsed, Refractory Disease.

Laura C Michaelis, MD, Danielle Shafer, DO, Kevin Barton, MD, Tulio Rodriguez, MD, Scott Smith, M.D., Ph.D, Patrick Stiff, MD, Sucha Nand, MD

Blood (2009) 114 (22): 1034.

https://doi.org/10.1182/blood.V114.22.1034.1034

Published: 2009

Journal Articles

CD4 Cell Count of More Than 250/Microl in the Peripheral Blood Is Associated with Improved Overall Survival in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Independent of the aaIPI

Hossein Borghaei, DO, MS, Mitchell Smith, MD, Ph.D., Michael Millenson, Tianyu Li, Danielle Shafer, DO, Tahseen I. Al-Saleem, MD

Blood (2008) 112 (11): 3775.

https://doi.org/10.1182/blood.V112.11.3775.3775

Published: 2008

Journal Articles

Peripheral Blood CD3 + CD4 + and CD3 − CD56 + Cell Counts and Circulating Lymphoma Cells Are Significant Predictors of Overall Survival in Newly Diagnosed Follicular Lymphoma.

Danielle Shafer, DO, Mitchell R. Smith, MD, PhD, Samuel Litwin, PhD, Tianyu Li, Hossein Borghaei, DO, Tahseen I. Al-Saleem, MD

Blood (2007) 110 (11): 2607.

https://doi.org/10.1182/blood.V110.11.2607.2607

Published: 2007

Journal Articles

Phase I Trial of Combination Therapy with 90 Y Ibritumomab Tiuxetan and Gemcitabine in Patients with Non-Hodgkin’s Lymphoma.

Hossein Borghaei, DO, MS, Mitchell Smith, MD, Ph.D., Michael Millenson, MD, Danielle Shafer, DO, Linda Thibodeau, RN, Russell Schilder, MD

Blood (2006) 108 (11): 4710.

https://doi.org/10.1182/blood.V108.11.4710.4710

Published: 2006

Journal Articles

Vinblastine, Mitoxantrone and Prednisone (MVP) Followed by Involved Field Radiotherapy (IF-XRT) for Early Clinical Stage Hodgkins’s Lymphoma: Long Term Follow-Up.

Danielle Shafer, DO, Hossein Borghaei, DO, Michael Millenson, MD, Nicos Nicolaou, MD, Tahseen I. Al-Saleem, MD, Nick C. Leasure, MD, Kris Padavic, RN, Mitchell R. Smith, MD, PhD, Russell J. Schilder, MD

Blood (2005) 106 (11): 2677.

https://doi.org/10.1182/blood.V106.11.2677.2677

Published: 2005

NARROW

Venetoclax in Combination with Hypomethylating Agents Compared to Standard Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia

Primary Ocular Lymphoma: A SEER Database Analysis of Patterns of Involvement and Outcomes

Impact of Histologic Type on Survival in Primary Parotid Lymphomas

Favorable Outcomes of Acute Leukemia of Ambiguous Lineage Treated with Hypercvad: A Multi-Center Retrospective Study

Secondary Skin Involvement in Non-Hodgkin's Lymphoma Does Not Impact Outcomes: SEER Database Analysis

Disseminated histoplasmosis in peripheral blood smear

The Efficacy and Safety of the Addition of Rituximab to CHOP or a CHOP-Like Regimen In First Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Meta-Analysis

Azacitadine and Low-Dose Gemtuzumab Ozogamicin for the Treatment of Poor-Risk Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Relapsed, Refractory Disease.

CD4 Cell Count of More Than 250/Microl in the Peripheral Blood Is Associated with Improved Overall Survival in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Independent of the aaIPI

Peripheral Blood CD3 + CD4 + and CD3 − CD56 + Cell Counts and Circulating Lymphoma Cells Are Significant Predictors of Overall Survival in Newly Diagnosed Follicular Lymphoma.

Phase I Trial of Combination Therapy with 90 Y Ibritumomab Tiuxetan and Gemcitabine in Patients with Non-Hodgkin’s Lymphoma.

Vinblastine, Mitoxantrone and Prednisone (MVP) Followed by Involved Field Radiotherapy (IF-XRT) for Early Clinical Stage Hodgkins’s Lymphoma: Long Term Follow-Up.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only